Home Press Release Global Pet Insect Repellent Market to Grow at a CAGR of 6% by 2030.

Global Pet Insect Repellent Market to Grow at a CAGR of 6% by 2030.

Introduction

Insect repellents for pets ward off mosquitoes, ticks, flies, and other bite insects. Mosquitoes can transmit Zika virus, Malaria, and West Nile virus. Ticks can transmit diseases such as Lyme disease, and Rocky Mountain spotted fever. Repellents are not intended to kill insects but to keep them away to prevent bites and disease transmission.

The increased threat of diseases such as anemia, lame disease, tick paralysis, and itching caused by ticks and fleas is expected to raise the need for pet insect repellents significantly during the projected period. An increase in the number of pet owners in various developed and developing nations, an increase in vector-borne diseases, and an increase in pet health expenditures in developed countries are the factors driving the market growth. However, stringent regulations and toxicity in the chemicals impede the market growth.

Market Dynamics

Growing Trend of Pet Humanization to Drive the Global Pet Insect Repellent Market

Pet humanization has gained extensive coverage in mainstream media worldwide in recent years. Research undertaken by the American Pet Products Association (APPA) as part of the National Pet Owners Survey (2019-20) revealed that more than 85 million households in the United States owned one or more pets, with dogs constituting a significant proportion of the pet population. Thus, increased humanization of pets is predicted to fuel the pet insect repellent market.

The phrase "pet humanization" is gaining widespread acceptance in the global pet sector. More pet owners desire to provide their pets with human-like experiences and goods. Research undertaken by the American Pet Products Association (APPA) as part of the National Pet Owners Survey (2019-2020) indicated that more than 85 million U.S. households have one or more pets, with most families having dogs. Thus, it is projected that the rising humanization of pets will boost the pet insect repellent market.

Moreover, the European Pet Food Federation (FEDIAF) states that approximately 38 percent of EU homes have a pet. These households domesticate about 81 million cats, 71 million dogs, and 1 billion additional companion animals. Consequently, the increasing consumer trend toward pet adoption has propelled the market, which is predicted to expand globally throughout the forecast period.

Increase in Pet Health Expenditure to Provide Opportunities for the Global Pet Insect Repellent Market

The market for insect repellents for pets is thriving due to the rising cost of animal healthcare per capita. According to the American Pet Product Association (APPA), dog owners in the United States spent an average of $1,880 per canine in the preceding 12 months on pet food, treats, toys, vitamins, grooming, veterinarian appointments, and dog walking/kennel services. During the same period, cat owners spent an average of $902 per kitty. Vet costs are generally the most expensive portion of a pet owner's budget, and lack of access can be prohibitive for many individuals.

According to the Centers for Disease Control and Prevention, seven novel diseases transmitted via the bite of an infected tick were discovered in the United States between 2004 and 2016. Along with dogs, these pathogens can potentially infect humans and cause zoonotic illnesses.

As the prevalence of various diseases in companion animals rises, the national demand for diagnostic imaging procedures and disease-prevention supplements increases.

Consequently, the increasing awareness of pet health among pet owners and the rising expenditures on pet health are the factors driving the expansion of the investigated market.

Key Highlights

  • The global pet insect repellent market was valued at USD 14,240 million in 2021 and is estimated to reach an expected value of USD 24060 million by 2030, registering a CAGR of 6% during the forecast period (2022-2030).
  • By pet type, the global pet insect repellent market is segmented into dogs, cats, birds, and other animals. The dog segment accounted for the largest market share and is anticipated to grow at a CAGR of 6.4% during the forecast period.
  • By insect type, the global pet insect repellent market is segmented into ticks, flies, bees, fleas, and other insect types. The ticks segment accounted for the largest market share and is anticipated to grow at a CAGR of 6.5% during the forecast period.
  • By end user/application, the global pet insect repellent market is segmented into pet clinics, pet shops, and other end users/applications. The pet shop segment accounted for the largest market share and is anticipated to grow at a CAGR of 6.4% during the forecast period.

Regional Insights

By region, the global pet insect repellent market is segmented into North America, Europe, Asia Pacific, and SAMEA.

North America accounted for the largest market share and is anticipated to grow at a CAGR of 6.5% during the forecast period. The United States has the largest pet population in the world. 70% of US households have a pet, up from 67% in the 2019-2020 APPA National Pet Owners Poll, according to the 2021-2022 survey. During the pandemic, 14% of all respondents acquired a new pet. 35% of pet owners spent more on their pet/pet supplies, including food, wellness-related products, and other pet care items, such as bug repellants, predicted to fuel the market in the country over the last year.

The Asia Pacific is the second largest region. and is estimated to reach an expected value of USD 3730 million by 2030, registering a CAGR of 6.7%. The surge in pet health and hygiene goods, such as mosquito repellents, is partly attributable to China's increasing prosperity. According to official statistics, the country's GDP per capita exceeded $10,000. As the income of Chinese individuals rises, pet ownership and care are expanding. In China's growing markets, pet care is booming as the middle class moves away from purchasing dogs for security and lavishing them with affection. In addition to fundamental necessities such as food and water, other requirements must be met. As bug infestations are frequent among pets such as cats and dogs, the insect repellent market is also expanding.

Europe is the third largest region. As the weather heats in the country, invasive species such as mosquitoes, biting flies, horseflies, and ticks become active and assault humans and dogs. In 2020, the German Red Cross Society warned about potentially fatal infections such as Lyme disease and tick-borne encephalitis (TBE). In Germany, 164 districts were identified as TBE risk zones in 2020. They can be found mainly in Bavaria and Baden-Württemberg and in portions of Hesse, Rhineland-Palatinate, Saxony, Lower Saxony, Thuringia, and Saarland. Introducing effective products against ticks in these regions can assist market players in improving their market position. Thus, the rise in pet ownership and the rise in tick-borne diseases in pets are driving the market for insect repellents in the United States, which is expected to boost the industry.

Competitive Players

Competitive Landscape

The key player in the global pet insect repellent market is Merck And Co. Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Virbac,  Hartz Mountain Corporation, Tianjin Ringpu Bio-technology Co. Ltd, Zoetis Inc., Central Garden & Pet.

Recent Developments

Market News

  • September 2022 - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the company would initiate a new Phase 3 clinical program with once-daily islatravir for the treatment of people with HIV-1 infection.
  • September 2022 - Merck (NYSE: MRK), also known as MSD outside the United States and Canada, announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) had recommended the approval of VAXNEUVANCETM (Pneumococcal 15-valent Conjugate Vaccine) (pronounced VAKS-noo-vans) for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptoc VAXNEUVANCE is now approved for use in the European Union (EU) in patients aged 18 or older.

Segmentation

Global Pet Insect Repellent Market: Segmentation

By Pet Type

  • Dogs
  • Cats
  • Birds
  • Other Animals

By Insect Type

  • Ticks
  • Flies
  • Bees
  • Fleas
  • Other Insect Types

By End User / Application

  • Pet Clinic
  • Pet Shop
  • Other End Users/applications

By Region

  • North America
  • Europe
  • Asia Pacific
  • SAMEA

Want to see full report on
Pet Insect Repellent Market

Related Reports

WhatsApp
Chat with us on WhatsApp